• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX SA VIDAS® HCG

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX SA VIDAS® HCG Back to Search Results
Catalog Number 30405
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Event Description
Product description: vidas® hcg is an automated quantitative test for use on the vidas® family instruments, for the quantitative measurement of human chorionic gonadotropin in human serum or plasma (lithium heparin or edta) using the elfa technique (enzyme linked fluorescent assay).Issue description: on (b)(6) 2023, a customer from canada notified biomérieux of obtaining overestimated result when testing external quality control with vidas hcg 60 tests (ref.30405, batch number: 1009680630, expiry date: 03-oct-2023).The external quality control used by the customer is the level 1 (lot: 85301) from bio-rad liquichek immunoassay plus control (lot: 85300).The expected ranges according to bio-rad for level 1 is: 5.33 (3.34 ¿ 7.32) miu/ml.The customer obtained 2 values for level 1 that were out-of-range: 8.04 and 9.49 miu/ml.Due to this out of range result for qc sample, the patients' samples were sent to another laboratory, which delayed the results by two days.The number of concerned patients was not specified.Based on the available information at the time of this assessment, there is no indication or report from the laboratory that the delayed result led to any adverse event related to patient's state of health.A biomérieux internal investigation will be initiated.Note: reference (b)(4) is not registered in the united states.The u.S.Similar device is product reference (b)(4).
 
Manufacturer Narrative
An internal investigation was performed following a notification from a customer from canada who obtained overestimated result when testing external quality control with vidas hcg 60 tests (ref.(b)(4), batch number: 1009680630, expiry date: 03-oct-2023).1.Device history record the review did not highlight any issue during manufacturing for vidas hcg ref.(b)(4) lot 1009680630.2.Complaint analysis at the date of investigation, no others complaints were recorded for overestimated result on vidas hcg ref.(b)(4) lot.1009680630.3.Tests/analysis performed 3.1.Study of internal samples control charts: this analysis was carried out : - on 4 internal sera vidas hcg with targets between 4.29 to 156 mui/ml.- on 7 batches of vidas hcg including the batch mentioned by the customer all values are within their specifications, customer¿s lot is in the trend of the other lots.3.2.Study on internal samples: the complaints laboratory tested 3 internal samples with following targets (1.96-6.90), (1.84-6.74) and (2.51-7.71) on the retain kit vidas hcg ref (b)(4) lot 1009680630 (lot mentioned by the customer).Sample results are within their expected specifications.4.Root cause analysis and conclusion according to all information above, no anomaly was highlighted during the control chart analysis and the analysis of quality data for number vidas hcg ref.(b)(4) lot 1009680630.In the absence bio-rad qc samples, it is impossible to pursue further investigations.This quality control lot is no longer available for sale.The most likely hypothesis would be due for one or more of the causes listed below: - the quality control sample processed by the customer (e.G stability, homogenization, handling¿).- the instrument (respect of instructions of use related to preventive maintenance and monitoring with weekly qcv testing).- the calibration results.According to the investigation outcomes, there is no reconsideration of vidas hcg ref.(b)(4) lot 1009680630.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VIDAS® HCG
Type of Device
VIDAS® HCG
Manufacturer (Section D)
BIOMERIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR  69280
Manufacturer (Section G)
BIOMERIEUX SA
376 chemin de l'orme
marcy l'etoile 69280
FR   69280
Manufacturer Contact
sandra locca-bernard
5 rue des aqueducs
craponne 69290
FR   69290
MDR Report Key16752106
MDR Text Key313842023
Report Number8020790-2023-00028
Device Sequence Number1
Product Code JHI
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
K141133
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 06/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/17/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/03/2023
Device Catalogue Number30405
Device Lot Number1009680630
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/06/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/17/2022
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-